OneMedNet Corp (NASDAQ: ONMD) is a healthcare data company that aggregates, curates, and licenses medical imaging and Real World Data for use in clinical research and regulatory submissions. Revenue is generated through its iRWD (intelligent Real World Data) service platform, where life science companies and healthcare stakeholders pay for access to curated patient data and Real World Evidence prepared for regulatory review by bodies such as the FDA and European Medicines Agency. The company has built a network of hospitals, imaging centers, and clinics across the United States covering more than 31 million patient records as of the FY2025 10-K filing. It also operates internationally, with data relationships in Ireland, the United Kingdom, the Netherlands, Denmark, Germany, Canada, and South Korea. OneMedNet is pre-profitability, has disclosed ongoing operating losses, and has funded operations through private placements, shareholder loans, and a standby equity purchase agreement with Yorkville. Bitcoin purchases and sales have also been a component of investing activity in FY2024 and FY2025.

Revenue model

Service fees from the iRWD platform, under which life science companies and healthcare stakeholders pay for access to curated Real World Data and Real World Evidence packages suitable for FDA and EMA regulatory submissions. The company also holds Bitcoin as a treasury asset, generating intermittent proceeds from Bitcoin sales ($5.1 million in proceeds during FY2025).

Products and services

iRWD (intelligent Real World Data) platform: aggregates clinical imaging data, EHR records, patient-generated outcome data, claims data, and public health data; applies AI algorithms for digital image analysis and passive screening of large medical image databases; blends disparate data sources through probabilistic record matching; validates data through editable eCRFs; and prepares Real World Evidence packages for regulatory submissions to the FDA and EMA.

Customers and end markets

Life science companies, pharmaceutical and biotech firms conducting clinical trials, healthcare providers, payers, and regulators. End markets include clinical trial support, comparative effectiveness research, treatment effectiveness studies, and regulatory evidence generation.

Value-chain role

Intermediary data aggregator and curator sitting between Real World Data sources (hospitals, imaging centers, clinics) and end users (life science companies, regulators, healthcare payers). OneMedNet standardizes, blends, and packages data for downstream regulatory and research use.

Geographic exposure

Primarily United States, with international data relationships in Ireland, United Kingdom, Netherlands, Denmark, Germany, Canada, and South Korea, as disclosed in the FY2025 10-K filing.

Source: SEC 10-K, filed 2026-03-30

Industry: Services-Commercial Physical & Biological Research